Michel Keusch

Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG.

In May 2013, Kepler Capital Markets SA completed the acquisition of Crédit Agricole Cheuvreux SA from Crédit Agricole Corporate & Investment Bank SA, a unit of Crédit Agricole SA. Kepler Capital Markets intends to combine its business with Crédit Agricole Cheuvreux under a new entity, Kepler Cheuvreux, in 2013, and will be headquartered in Paris. They will have offices in Amsterdam, Boston, Frankfurt, Geneva, London, Madrid, Milan, New York, San Francisco, Stockholm, Vienna and Zurich.